Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Mulder

Showing results (311-320 of 369) with videos related to

Pageof 37
Sort By:
European Journal of Cancer & Clinical Oncology|December 1, 1985
High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II studyP E Postmus, N H Mulder, H G de Vries-Hospers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2010
FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrencesJ S de Jong, R J van Ginkel, R H J A Slart, et al.
Breast Cancer Research and Treatment|January 1, 1996
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.
British Journal of Cancer|January 1, 1997
A new in vitro assay for quantitation of chemotherapy-induced mucositisA N Wymenga, W T van der Graaf, F L Spijkervet, et al.
Oncology|January 1, 1983
Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effectsS Meijer, N H Mulder, D T Sleijfer, et al.
British Journal of Cancer|February 1, 1993
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 daysJ A Gietema, E G de Vries, D T Sleijfer, et al.
Blood|September 1, 1992
Effects of interleukin-3 after chemotherapy for advanced ovarian cancerB Biesma, P H Willemse, N H Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorinH A Sinnige, J Buter, E G de Vries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic studyE F Smit, P H Willemse, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicinE G de Vries, J Greidanus, N H Mulder, et al.
Pageof 37

Showing results (311-320 of 369) with videos related to

Sort By:
Pageof 37
European Journal of Cancer & Clinical Oncology|December 1, 1985
High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II studyP E Postmus, N H Mulder, H G de Vries-Hospers, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 11, 2010
FDG-PET probe-guided surgery for recurrent retroperitoneal testicular tumor recurrencesJ S de Jong, R J van Ginkel, R H J A Slart, et al.
Breast Cancer Research and Treatment|January 1, 1996
Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancerE G de Vries, S Rodenhuis, H C Schouten, et al.
British Journal of Cancer|January 1, 1997
A new in vitro assay for quantitation of chemotherapy-induced mucositisA N Wymenga, W T van der Graaf, F L Spijkervet, et al.
Oncology|January 1, 1983
Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effectsS Meijer, N H Mulder, D T Sleijfer, et al.
British Journal of Cancer|February 1, 1993
A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 daysJ A Gietema, E G de Vries, D T Sleijfer, et al.
Blood|September 1, 1992
Effects of interleukin-3 after chemotherapy for advanced ovarian cancerB Biesma, P H Willemse, N H Mulder, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I-II study of the addition of alpha-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of alpha-2a interferon and leucovorinH A Sinnige, J Buter, E G de Vries, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1991
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic studyE F Smit, P H Willemse, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1987
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicinE G de Vries, J Greidanus, N H Mulder, et al.
Pageof 37